AmpliMed

Oncology company announces two senior appointments

Published in Lab Business Week, April 24th, 2005

AmpliMed announced the promotion of Evan Hersh, MD, to executive VP, medical affairs and chief medical officer and the addition of Wayne Morrison as director of finance and administration.

As a cofounder of AmpliMed, Hersh led the rediscovery of Amplimexon (imexon inj.) as an anticancer drug. Amplimexon is now the lead drug candidate in AmpliMed's clinical development portfolio. As executive VP, Hersh will assume full responsibility for the planning and execution of all AmpliMed's clinical and scientific development programs.

Morrison brings more than 2 decades of experience in operations, finance and accounting in the healthcare industry to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2005-04-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry